A respiratory therapy management system includes intelligent valved holding chamber devices (IVHCs) corresponding to patients. Each IVHC generates air inflow data during an inhalation therapy session, and determines an inhalation technique score for the session. For each IVHC, a mobile computing device receives and processes inhalation technique scores; generates composite inhalation technique scores and inhalation therapy regimen compliance scores corresponding to multiple inhalation therapy sessions; and presents visual representations of such scores. A remote therapy management server manages patient incentive awards; provides a social media platform and/or games accessible to patients; and communicates with physician computing devices to facilitate physician review of composite inhalation technique scores and inhalation therapy regimen compliance scores, and physician access to the social media platform. For a given patient, provision of incentive awards, aspects of social media interaction, and/or game play depend upon their composite inhalation technique scores and/or inhalation therapy regimen compliance scores.

A composite ion conducting tube is made by wrapping a support material or ion conducting sheet to from a tube having overlaps of layers that are bonded. The ion conducting sheet or tape used to make the tube may be very thin and the tube may be formed in situ by wrapping the support material and then coating with ion conducting polymer. The ion conducting tubes may be used in a pervaporation module or desalination system. The ion conducting tubes may be spirally wrapped or longitudinally wrapped and may be very thin having a tube wall thickness of no more than 25 microns.

A control system for administration of a drug comprises a drug administration actuator for administering the drug to a patient at a controllable dosage; a monitor for measuring an effect of the drug on the patient; and a controller configured to determine a control signal to the drug administration actuator; wherein the controller is configured to implement a closed loop model-predictive control scheme comprising, for each of a series of time steps, minimizing a cost function subject to one or more constraints to determine the control signal, the cost function based at least in part on a reference level and the monitor measurement; wherein the control signal is used as an input to an auxiliary model to estimate at least one concentration level of the drug in the patient; and wherein the constraints comprise at least one constraint on the estimate of the concentration level of the drug.

Module for housing electronic and electromechanical medical equipment including a portable digital camera and processing circuitry with machine vision and machine learning software for automatically documenting healthcare events and healthcare equipment operations in the electronic health record.

Disclosed is a device for providing resuscitation or suspended state through redistribution of cardiac output to increase supply to the brain and heart for a patient. The device includes an electrically controllable redistribution component attachable to the patient to provide redistribution of the cardiac output to increase supply to the brain and heart. The redistribution component, following a predefined reaction pattern based on an electrical signal, and computer means configured to: receive a patient data which identifies physiological and/or anatomical characteristics of the patent; and provide the electrical signal for the redistribution component based on the patient data or a standard response. The device may provide mechanisms to protect the aorta and the remaining anatomy of the patient from inadvertent damage caused by the disclosed device in any usage scenario of either correct intended usage or unintended usage. Also disclosed is a method for providing resuscitation or suspended state.

Mouth-breathing can be detected in early phase expiration during respiratory treatments involving a pressure support device. In accordance with some embodiments, an output signal is received from a sensor that conveys information relating to one or more parameters of the pressurized flow of breathable gas as it is delivered to an air-way of a subject. Transitions are estimated between inspiratory phases and expiratory phases of respiration by the subject based on the one or more determined parameters. A local extreme is identified in a level of a first parameter during a given expiratory phase of respiration by the subject. The level of the first parameter is analyzed as a function of time within a sampling window to determine whether the subject is breathing by mouth during the given expiratory phase. The sampling window begins at or proximate to the identified local extreme in the level of the first parameter.

Methods of respiratory support and related respiratory support apparatus are disclosed. The methods may include a first step of communicating only a respiratory gas from a gas source into a regulator chamber of a regulator during inhaling by a user and a second step of communicating ambient air from an ambient environment into the regulator chamber during inhaling by the user. The first step and the second step are sequenced thereby communicating only the respiratory gas into lungs of the user during the first step and communicating the ambient air into an anatomical dead space of the user during the second step.

A butyric acid detection based platform for verifying placement of a patient airway device or a gastric tube comprising at least one of i) a colorimetric based butyric acid detection platform, ii) a bioelectronic sensors based butyric acid detection platform using olfactory receptors, and iii) an IR based butyric acid detection platform. Each platform comprises a housing coupled to the patient airway device or gastric tube whereby flow from the coupled patient airway device or a gastric tube can flow through an internal passage of the housing; and wherein sensors within the housing come into contact with the flow from the coupled patient airway device or a gastric tube, the sensors including at least one of a chemical sensor array including at least one of i) colorimetric based butyric acid sensor, ii) a bioelectronic butyric acid detection sensor using olfactory receptors, and iii) an IR based butyric acid sensor.

An apparatus assesses a condition of a patient. The apparatus may contain a patient interface for communicating a treatment generated by a respiratory treatment apparatus to the respiratory system of a patient. The apparatus may also include a sensing module containing one or more electrochemical sensors to sense chemicals in exhaled breath in real time, or over an extended period of time. The apparatus may also include one or more collectors to accumulate a breath condensate over an extended period of time. The sample collectors may contain an absorbent material, and may also be adapted for replacement within a sensing module. The absorbent material may also include a preservative for preserving a chemical component of the breath, such as an analyte of the exhaled breath. The technology may provide treatment recommendations based on the detected condition of the breath condensate or the chemical components thereof

An apparatus assesses a condition of a patient. The apparatus may contain a patient interface for communicating a treatment generated by a respiratory treatment apparatus to the respiratory system of a patient. The apparatus may also include a sensing module containing one or more electrochemical sensors to sense chemicals in exhaled breath in real time, or over an extended period of time. The apparatus may also include one or more collectors to accumulate a breath condensate over an extended period of time. The sample collectors may contain an absorbent material, and may also be adapted for replacement within a sensing module. The absorbent material may also include a preservative for preserving a chemical component of the breath, such as an analyte of the exhaled breath. The technology may provide treatment recommendations based on the detected condition of the breath condensate or the chemical components thereof